SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601830-24-000072
Filing Date
2024-06-05
Accepted
2024-06-05 18:12:17
Documents
1
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1717625527.html 4  
1 FORM 4 wk-form4_1717625527.xml 4 5732
  Complete submission text file 0001601830-24-000072.txt   7269
Mailing Address 3005 FIRST AVENUE SEATTLE WA 98121
Business Address
HERSHBERG ROBERT (Reporting) CIK: 0001274139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 241023291

Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)